Similac, Pediasure Drive Abbott’s Ross Sales In 2007
This article was originally published in The Tan Sheet
Executive Summary
Similac, PediaSure and the launch of NutriPals bars and shakes drove sales by Abbott Laboratories' Ross U.S. Nutritionals unit up 3 percent to $624 million in its fourth quarter, according to Abbott President and COO Rick Gonzalez
You may also be interested in...
Abbott Credits International Markets For Present, Future Growth
International sales of Abbott's nutritional products increased 15.6 percent to $515 million in its latest quarter as a result of "focused promotional efforts and sales force activities," the firm said Oct. 17
Abbott Credits International Markets For Present, Future Growth
International sales of Abbott's nutritional products increased 15.6 percent to $515 million in its latest quarter as a result of "focused promotional efforts and sales force activities," the firm said Oct. 17
Abbott Credits International Markets For Present, Future Growth
International sales of Abbott's nutritional products increased 15.6 percent to $515 million in its latest quarter as a result of "focused promotional efforts and sales force activities," the firm said Oct. 17